# FDA Inspection 1161713 - KITE PHARMA INC - January 28, 2022

Source: https://www.keypedia.com/records/fda_inspections/kite-pharma-inc/d06d0ccc-a7a5-4bee-87f5-d924fc0d5f7c
Source feed: FDA_Inspections

> FDA Inspection 1161713 for KITE PHARMA INC on January 28, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1161713
- Company Name: KITE PHARMA INC
- Inspection Date: 2022-01-28
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

Company: https://www.keypedia.com/companies/kite-pharma-inc/dcb874e6-c0b9-4398-85d8-d50edd95cca6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d